Recruiting NCT07116564
Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Enhanced Recovery After Surgery, Control.
- Who it may be relevant to
- Registry conditions: ERAS. Basic parameters: 20 years — 60 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Pakistan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Impact of Multimodal Analgesia and ERAS Protocol on Length of Hospital Stay After Laparoscopic Gynecological Surgeries: A Randomized Control Trial
Overview
The goal of this clinical trial is to determine the length of hospital stay in patients using multimodal analgesia with or without ERAS protocol scheduled for elective laparoscopic gynecological surgeries
Interventions
- Drug Enhanced Recovery After Surgery
Preoperatively ERAS protocol includes, No solid food for 6 hours before procedure; 800 ml (fantomalt powder) Carbohydrate drink 8 hours before surgery; 400 ml (fantomalt powder) 2 hours before surgery; Celecoxib 200g 1 hour before surgery . Intraoperatively, on induction lidocaine 1.5 mg/kg and Fentanyl 1 to 2 mcg/kg followed by IV lidocaine infusion at 1.5 mg/kg/h. - Drug Control
Preoperatively, NPO 6 hours before the procedure Intraoperatively, on induction Nabuphine 0.1mg/kg
Primary outcome measures
- Length of hospital stay [Time frame: From arrival in the recovery room post-surgery until 72 hours after surgery.]
Secondary outcome measures (3)
- Postoperative pain score [Time frame: 4 hours, 8 hours, 12 hours, 24 hours, 48 hours & 72 hours postoperatively]
- Amount of opioid used in patient controlled analgesia [Time frame: 12 hours postoperatively.]
- Patient satisfaction Score [Time frame: 24 hours after the operation]
Eligibility criteria
Inclusion criteria
- ASA physical status I, II, and III
- Patients scheduled for elective laparoscopic gynecological surgeries
Exclusion criteria
- Refusal to participate
- History of allergy or contraindication to study drugs
- Patients in which procedure converted to open surgery
- Diagnostic laparoscopic procedures
- Patients with a history of severe anxiety or depression
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Pakistan · 1 center
- Aga Khan University, Karachi, Pakistan — Karachi
Identifiers
NCT: NCT07116564 · 2025-11268-35403